               SEQUENCE LISTING

<110> Polaris Pharmaceuticals. Inc.

<120> METHODS AND KITS FOR IDENTIFYING SUBJECTS RESPONSIVE TO ARGININE DEPRIVATION THERAPY

<130> P4166-PCT_specification 

<160> 9

<170> BiSSAP 1.3.6

<210> 1
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 1
acttctgaca gccatccaga                                                20


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 2
atcctgctag catgttgact                                                20


<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 3
actgtagatg ccttccatct                                                20


<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 4
acattcacag agaacttggc                                                20


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 5
caagcagtcc ttccaccttg                                                20


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 6
aaagtgctgg gattacaggt                                                20


<210> 7
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 7
tcacgaggcc aacattctag                                                20


<210> 8
<211> 20
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 8
ttagattctg catggctcac                                                20


<210> 9
<211> 21
<212> DNA
<213> Artificial Sequence


<220> 
<223> Synthetic

<400> 9
tccctcctac tgaacctctc c                                              21


